Cargando…

Long-term Outcome after Prophylactic Lamivudine Treatment on Hepatitis B Virus Reactivation in Non-Hodgkin's Lymphoma

Hepatitis B virus (HBV) reactivation is the frequent complication after cytotoxic chemotherapy in HBsAg-positive non-Hodgkin's lymphoma (NHL) patients. Pre-chemotherapy viral load may be a risk factor and HBeAg-positive status is associated with increased viral load. The aim of this study was t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jin Seok, Hahn, Jee Sook, Park, Sun Young, Kim, Yuri, Park, In Hae, Lee, Chun Kyon, Cheong, June-Won, Lee, Seung Tae, Min, Yoo Hong
Formato:	Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2007
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2627995/ https://www.ncbi.nlm.nih.gov/pubmed/17326249 http://dx.doi.org/10.3349/ymj.2007.48.1.78

Ejemplares similares

High Dose Chemotherapy and Autologous Stem Cell Transplantation in Non-Hodgkin's Lymphoma: an Eight-Year Experience
por: Chang, Hyun, et al.
Publicado: (2006)

The prophylactic use of lamivudine can maintain dose-intensity of adriamycin in hepatitis-B surface antigen (HBs Ag)-positive patients with Non-Hodgkin's lymphoma who receive cytotoxic chemotherapy.
por: Lee, Gyeong-Won, et al.
Publicado: (2003)

The Effect of Prophylactic Lamivudine plus Adefovir Therapy Compared with Lamivudine Alone in Preventing Hepatitis B Reactivation in Lymphoma Patients with High Baseline HBV DNA during Chemotherapy
por: Cai, Qingqing, et al.
Publicado: (2016)

Nine-Year Survival of Lymphoblastic Lymphoma Patients
por: Kang, Wonseok, et al.
Publicado: (2006)

Treatment of Hodgkin's Disease: A Twenty-Year Follow-up of Patients at a Center in Korea
por: Cheong, June-Won, et al.
Publicado: (2006)

Therapeutic Comparison of Chemotherapy and Surgery for Early Stage Diffuse Large B-cell Gastric Lymphoma
por: Kim, Soo-Jeong, et al.
Publicado: (2007)

Comparison of tenofovir plus lamivudine versus tenofovir monotherapy in patients with lamivudine-resistant chronic hepatitis B
por: Park, Chan Ho, et al.
Publicado: (2016)

BRAF mutations in non-Hodgkin's lymphoma
por: Lee, J W, et al.
Publicado: (2003)

Rescue therapy with adefovir in decompensated liver cirrhosis patients with lamivudine-resistant hepatitis B virus
por: Woo, Hyun Young, et al.
Publicado: (2014)

Prophylactic Effect of Lamivudine for Chemotherapy-Induced Hepatitis B Reactivation in Breast Cancer: A Meta-Analysis
por: Tang, Wei, et al.
Publicado: (2015)

An Unusual Case of Spontaneous Remission of Hodgkin's Disease after a Single Cycle of COPP-ABV Chemotherapy Followed by Infectious Complications
por: Bang, Seungmin, et al.
Publicado: (2005)

Autoimmune Hemolytic Anemia in a Patient with Primary Ovarian Non-Hodgkin's Lymphoma
por: Jung, Chang Kil, et al.
Publicado: (2004)

Different roles of surveillance positron emission tomography according to the histologic subtype of non-Hodgkin’s lymphoma
por: Kim, Yu Ri, et al.
Publicado: (2021)

Detection of MYD88 L265P in patients with lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia and other B-cell non-Hodgkin lymphomas
por: Shin, Sang-Yong, et al.
Publicado: (2016)

Ruxolitinib shows activity against Hodgkin lymphoma but not primary mediastinal large B-cell lymphoma
por: Kim, Seok Jin, et al.
Publicado: (2019)

Usefulness of Flow Cytometric Analysis for Detecting Leptomeningeal Diseases in Non-Hodgkin Lymphoma
por: Shin, Sang-Yong, et al.
Publicado: (2016)

Prophylactic use of lamivudine for hepatitis B exacerbation in post-operative breast cancer patients receiving anthracycline-based adjuvant chemotherapy
por: Yun, J, et al.
Publicado: (2011)

Evaluating the efficacy of switching from lamivudine plus adefovir to tenofovir disoproxil fumarate monotherapy in lamivudine-resistant stable hepatitis B patients
por: Lee, Heon Ju, et al.
Publicado: (2018)

Prophylactic antibiotics may not be necessary for transoral endoscopic thyroidectomy
por: Lee, Jun Sung, et al.
Publicado: (2022)

Primary gastric Hodgkin's lymphoma
por: Jung, Ji-Han, et al.
Publicado: (2012)

A Case of CMV Disease of the Jejunum in a Patient with Non-Hodgkin’s Lymphoma
por: Han, Ki Ju, et al.
Publicado: (1998)

Bone Marrow Flow Cytometry in Staging of Patients With B-cell Non-Hodgkin Lymphoma
por: Kim, Borahm, et al.
Publicado: (2015)

Hepatitis B Virus Infection and B‐Cell Non‐Hodgkin's Lymphoma in a Hepatitis B Endemic Area: A Case‐control Study
por: Kim, Jee Hyun, et al.
Publicado: (2002)

The effectiveness of the appropriate prophylactic antibiotic use program for surgery
por: Lee, Eunjung, et al.
Publicado: (2023)

Long-Term Outcomes and Dynamics of Mutants Associated with Lamivudine-Adefovir Rescue Therapy in Patients with Lamivudine-Resistant Chronic Hepatitis B
por: Kim, Jihyun, et al.
Publicado: (2015)

A Case of Coincident Multiple Myeloma and Non-Hodgkin’s Lymphoma
por: Lee, Geun Chan, et al.
Publicado: (1994)

Are prophylactic haematopoietic growth factors of value in the management of patients with aggressive non-Hodgkin's lymphoma?
por: Hackshaw, A, et al.
Publicado: (2004)

Langerhans Cell Histiocytosis Followed by Hodgkin's Lymphoma
por: Park, IK Soo, et al.
Publicado: (2012)

Hepatitis B Reactivation in the Treatment of Non-Hodgkin Lymphoma
por: Kelling, Matthew, et al.
Publicado: (2018)

Peripheral T Cell Non-Hodgkin's Lymphoma following Treatment of Hodgkin's Lymphoma
por: Chang, Sun Hee, et al.
Publicado: (2015)

Risk of non-Hodgkin lymphoma in breast cancer survivors: a nationwide cohort study
por: Kang, Danbee, et al.
Publicado: (2021)

Aberrant synaptophysin expression in classic Hodgkin lymphoma
por: Im, Soyoung, et al.
Publicado: (2022)

Lack of usefulness of computed tomography for surveillance in patients with aggressive non-Hodgkin lymphoma
por: Kang, Ka-Won, et al.
Publicado: (2018)

Risk factors predicting graft-versus-host disease and relapse-free survival after allogeneic hematopoietic stem cell transplantation in relapsed or refractory non-Hodgkin’s lymphoma
por: Jeon, Young-Woo, et al.
Publicado: (2019)

Pulmonary Hodgkin Lymphoma in a Patient with Crohn’s Disease
por: Park, Jae-Young, et al.
Publicado: (2014)

Rituximab plus Ifosfamide, Carboplatin and Etoposide for T-Cell/Histiocyte-Rich B-Cell Lymphoma Arising in Nodular Lymphocyte-Predominant Hodgkin's Lymphoma
por: Park, Hyung-Chul, et al.
Publicado: (2012)

Novel Targeted Agents in Hodgkin and Non-Hodgkin Lymphoma Therapy
por: Grover, Natalie S., et al.
Publicado: (2015)

Prophylactic Tocilizumab Prior to Anti-CD19 CAR-T Cell Therapy for Non-Hodgkin Lymphoma
por: Caimi, Paolo F., et al.
Publicado: (2021)

A Korean Post-Marketing Study of Abacavir/Dolutegravir/Lamivudine in Patients with HIV-1
por: Shin, Sang-Kyu, et al.
Publicado: (2023)

Non-Hodgkin’s Lymphoma of the Thyroid and Adrenal Glands
por: Lee, Dae Ho, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_81gl2kv0g89fsu6pqsdo0frk59